Maridebart Cafraglutide
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Amgen · Phase 3 · Recruiting · Enrollment 3200
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.